newsfilter
← Latest News
GlobeNewswire·

Aclarion Highlights Growing Adoption of Nociscan at The London Clinic with New Physician Video

ACONACONW
  • Aclarion, Inc. (NASDAQ: ACON, ACONW) released a video featuring John Sutcliffe, Consultant Spinal Neurosurgeon & Lead Clinician at The London Spine Clinic, regarding his clinical experience with Nociscan.
  • Nearly 100 Nociscan procedures have been performed at The London Clinic, indicating increasing adoption for evaluating chronic low back pain.
  • Nociscan is a non-invasive SaaS platform using MR spectroscopy & proprietary augmented intelligence algorithms to differentiate between painful & non-painful lumbar discs.
  • Mr. Sutcliffe states that Nociscan provides objective data that complements traditional imaging to improve clinical decision-making confidence.
  • CEO Brent Ness noted that approaching 100 scans at a leading international center reinforces Nociscan's potential as a valuable diagnostic tool.
  • Clinical data indicates a 97% surgical success rate when all Nociscan-positive discs are treated alongside other diagnostic tools.
  • Chronic low back pain affects approximately 266 million people globally, presenting a significant healthcare challenge.